Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial

BACKGROUND: Approximately 10%–15% of people with diabetes develop at least one foot ulcer during their lifetime. Treatment of diabetic foot ulcers (DFUs) represents a significant economic burden. Enzymatic debridement with clostridial collagenase ointment (CCO) can be used to remove necrotic tissue...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Foot Ankle Res
Egile Nagusiak: Motley, Travis A, Gilligan, Adrienne M, Lange, Darrell L, Waycaster, Curtis R, Dickerson, Jaime E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4357050/
https://ncbi.nlm.nih.gov/pubmed/25767565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13047-015-0065-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak